Marshall Wace, LLP Legend Biotech Corp Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Legend Biotech Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 361,562 shares of LEGN stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
361,562
Previous 494,367
26.86%
Holding current value
$11.9 Million
Previous $24.1 Million
51.16%
% of portfolio
0.01%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$248 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$225 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$197 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$189 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$188 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.52B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...